Cite
HARVARD Citation
Araki, E. et al. (n.d.). Efficacy and safety of once‐weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once‐daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open‐label, phase III, non‐inferiority study. Diabetes, obesity & metabolism. 17 (10), pp. 994-1002. [Online].